PDS Biotechnology Corp (PDSB)
3.775
+0.04
(+1.21%)
USD |
NASDAQ |
May 07, 16:00
3.77
0.00 (0.00%)
Pre-Market: 20:00
PDS Biotechnology Price: 3.775 for May 7, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 07, 2024 | 3.75 | 3.88 | 3.535 | 3.775 | 587687.0 |
May 06, 2024 | 3.85 | 3.998 | 3.71 | 3.73 | 775623.0 |
May 03, 2024 | 3.85 | 3.96 | 3.74 | 3.82 | 430970.0 |
May 02, 2024 | 3.66 | 3.74 | 3.57 | 3.73 | 375315.0 |
May 01, 2024 | 3.35 | 3.82 | 3.31 | 3.61 | 675778.0 |
Apr 30, 2024 | 3.37 | 3.38 | 3.255 | 3.35 | 258935.0 |
Apr 29, 2024 | 3.27 | 3.52 | 3.254 | 3.39 | 436535.0 |
Apr 26, 2024 | 3.24 | 3.38 | 3.20 | 3.27 | 415645.0 |
Apr 25, 2024 | 3.14 | 3.29 | 3.121 | 3.26 | 421721.0 |
Apr 24, 2024 | 3.25 | 3.30 | 3.19 | 3.25 | 447158.0 |
Apr 23, 2024 | 3.00 | 3.25 | 2.99 | 3.20 | 990581.0 |
Apr 22, 2024 | 2.65 | 3.00 | 2.64 | 2.99 | 684226.0 |
Apr 19, 2024 | 2.89 | 2.915 | 2.59 | 2.645 | 881528.0 |
Apr 18, 2024 | 2.72 | 3.015 | 2.69 | 2.90 | 1.128M |
Apr 17, 2024 | 2.84 | 2.84 | 2.68 | 2.72 | 610937.0 |
Apr 16, 2024 | 2.81 | 2.925 | 2.68 | 2.80 | 717504.0 |
Apr 15, 2024 | 3.20 | 3.241 | 2.805 | 2.82 | 1.321M |
Apr 12, 2024 | 3.33 | 3.38 | 3.14 | 3.19 | 595599.0 |
Apr 11, 2024 | 3.19 | 3.41 | 3.19 | 3.37 | 587003.0 |
Apr 10, 2024 | 3.14 | 3.20 | 3.07 | 3.15 | 517188.0 |
Apr 09, 2024 | 3.31 | 3.31 | 3.095 | 3.27 | 937713.0 |
Apr 08, 2024 | 3.27 | 3.40 | 3.14 | 3.31 | 620889.0 |
Apr 05, 2024 | 3.24 | 3.375 | 3.171 | 3.23 | 904020.0 |
Apr 04, 2024 | 3.69 | 3.73 | 3.22 | 3.29 | 1.424M |
Apr 03, 2024 | 3.76 | 3.77 | 3.61 | 3.68 | 691298.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6493
Minimum
Apr 02 2020
17.08
Maximum
Sep 23 2021
5.470
Average
5.22
Median
Apr 21 2022
Price Benchmarks
Syros Pharmaceuticals Inc | 5.12 |
PAVmed Inc | 2.28 |
Altimmune Inc | 7.28 |
Regeneron Pharmaceuticals Inc | 969.97 |
iBio Inc | 2.00 |
Price Related Metrics
Price to Book Value | 5.299 |
Earnings Yield | -36.82% |
Market Cap | 138.46M |